Last reviewed · How we verify
NCT06917378
TRIO CTO (Taiwan Research Initiative on Coronary Total Occlusion)
trial testing Percutaneous coronary intervention of coronary chronic total occlusion in Chronic Total Occlusion (CTO) in 5,000 participants. Currently enrolling.
31 December 2034
Quick facts
| Lead sponsor | National Taiwan University Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 5,000 |
| Start date | 1 January 2017 |
| Primary completion | 31 December 2034 |
| Estimated completion | 31 December 2034 |
| Sites | 3 locations across Taiwan |
Drugs / interventions tested
- Percutaneous coronary intervention of coronary chronic total occlusion
Conditions studied
- Chronic Total Occlusion (CTO) — all drugs for Chronic Total Occlusion (CTO) →
Sponsor
National Taiwan University Hospital
Who can join
Adults 20 to 120, any sex, with Chronic Total Occlusion (CTO). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Coronary chronic total occlusions (CTO) present a significant challenge in the field of interventional cardiology. These complex lesions, characterized by complete blockage of a coronary artery for a prolonged duration, often require specialized techniques and strategies to achieve successful revascularization.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06917378
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Total Occlusion (CTO)
Currently open trials in the same condition.
- NCT07442526 — AGECTO Study: PCI vs. Optimal Medical Therapy for CTO in the Octogenarian Patients · active not recruiting
- NCT07463664 — Clinical Outcomes of Drug-Coated Balloons in the Treatment of Patients With Coronary De Novo Chronic Total Occlusion Les · NA · recruiting
- NCT07020858 — FAPI Imaging Predicts Adverse Cardiac Events in Chronic Total Occlusion · recruiting
- NCT07114393 — Optimization of Complex Percutaneous Coronary Intervention With Liberal Use of Intracoronary Imaging Versus Contemporary · recruiting
- NCT06655922 — FAPI Imaging Assessment of Chronic Total Occlusion · recruiting
Other National Taiwan University Hospital trials
Trials by the same sponsor.
- NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
- NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
- NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
- NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
- NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06917378 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
- Last refreshed: 18 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06917378.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing